Salud financiera de hoja de balance de Zydus Lifesciences
Salud financiera controles de criterios 6/6
Zydus Lifesciences tiene un patrimonio de accionistas total de ₹241.5B y una deuda total de ₹1.5B, lo que sitúa su ratio deuda-patrimonio en 0.6%. Sus activos y pasivos totales son ₹314.5B y ₹72.9B respectivamente. El BAIT de Zydus Lifesciences es de ₹53.8B, por lo que su ratio de cobertura de intereses es de -100.4. Tiene efectivo e inversiones a corto plazo que ascienden a ₹25.0B.
Información clave
0.6%
Ratio deuda-patrimonio
₹1.50b
Deuda
| Ratio de cobertura de intereses | -100.4x |
| Efectivo | ₹24.95b |
| Patrimonio | ₹241.55b |
| Total pasivo | ₹72.91b |
| Activos totales | ₹314.46b |
Actualizaciones recientes sobre salud financiera
Zydus Lifesciences (NSE:ZYDUSLIFE) Could Easily Take On More Debt
Jun 10
Zydus Lifesciences (NSE:ZYDUSLIFE) Could Easily Take On More Debt
Dec 27We Think Zydus Lifesciences (NSE:ZYDUSLIFE) Can Stay On Top Of Its Debt
Jul 15Zydus Lifesciences (NSE:ZYDUSLIFE) Seems To Use Debt Quite Sensibly
Feb 15Recent updates
Zydus Lifesciences Limited (NSE:ZYDUSLIFE) Just Reported Earnings, And Analysts Cut Their Target Price
Nov 15Here's Why We Think Zydus Lifesciences (NSE:ZYDUSLIFE) Is Well Worth Watching
Sep 14Zydus Lifesciences Limited's (NSE:ZYDUSLIFE) Business And Shares Still Trailing The Market
Aug 30Zydus Lifesciences Limited Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions
Aug 14Zydus Lifesciences Limited's (NSE:ZYDUSLIFE) CEO Compensation Is Looking A Bit Stretched At The Moment
Aug 03Zydus Lifesciences (NSE:ZYDUSLIFE) Will Pay A Smaller Dividend Than Last Year
Jul 19Zydus Lifesciences' (NSE:ZYDUSLIFE) Shareholders Will Receive A Smaller Dividend Than Last Year
Jul 05Zydus Lifesciences (NSE:ZYDUSLIFE) Will Pay A Smaller Dividend Than Last Year
Jun 20Zydus Lifesciences (NSE:ZYDUSLIFE) Could Easily Take On More Debt
Jun 10Zydus Lifesciences (NSE:ZYDUSLIFE) Will Pay A Smaller Dividend Than Last Year
May 25Does Zydus Lifesciences (NSE:ZYDUSLIFE) Deserve A Spot On Your Watchlist?
Mar 18Earnings Not Telling The Story For Zydus Lifesciences Limited (NSE:ZYDUSLIFE) After Shares Rise 28%
Feb 28Analyst Estimates: Here's What Brokers Think Of Zydus Lifesciences Limited (NSE:ZYDUSLIFE) After Its Third-Quarter Report
Feb 12Zydus Lifesciences (NSE:ZYDUSLIFE) Could Easily Take On More Debt
Dec 27Here's Why Zydus Lifesciences (NSE:ZYDUSLIFE) Has Caught The Eye Of Investors
Dec 06With EPS Growth And More, Zydus Lifesciences (NSE:ZYDUSLIFE) Makes An Interesting Case
Aug 23Zydus Lifesciences' (NSE:ZYDUSLIFE) Dividend Will Be Increased To ₹6.00
Jul 17We Think Zydus Lifesciences (NSE:ZYDUSLIFE) Can Stay On Top Of Its Debt
Jul 15Zydus Lifesciences' (NSE:ZYDUSLIFE) Upcoming Dividend Will Be Larger Than Last Year's
Jun 24Zydus Lifesciences (NSE:ZYDUSLIFE) Is Increasing Its Dividend To ₹6.00
Jun 10Zydus Lifesciences' (NSE:ZYDUSLIFE) Dividend Will Be Increased To ₹6.00
May 21Zydus Lifesciences (NSE:ZYDUSLIFE) Seems To Use Debt Quite Sensibly
Feb 15Análisis de la situación financiera
Pasivos a corto plazo: Los activos a corto plazo (₹121.6B) de ZYDUSLIFE superan a sus pasivos a corto plazo (₹53.5B).
Pasivo a largo plazo: Los activos a corto plazo de ZYDUSLIFE (₹121.6B) superan a sus pasivos a largo plazo (₹19.4B).
Historial y análisis de deuda-patrimonio
Nivel de deuda: ZYDUSLIFE tiene más efectivo que su deuda total.
Reducción de la deuda: El ratio deuda-patrimonio de ZYDUSLIFE ha pasado de 61.1% a 0.6% en los últimos 5 años.
Cobertura de la deuda: La deuda de ZYDUSLIFE está bien cubierta por el flujo de caja operativo (3062.5%).
Cobertura de intereses: ZYDUSLIFE gana más intereses de los que paga, por lo que la cobertura de pagos de intereses no es preocupante.